Notable Labs, a San Francisco-based AI-driven cancer treatment startup, has raised $40 million in a Series B round, co-led by the Eduardo Saverin’s VC fund B Capital Group and its existing investor LifeForce Capital.
In a statement received on Wednesday, the Series B round brings Notable’s total funding to more than $55 million. The company raised $14.8 million in a Series A round in September 2017.
